HuGE Literature Finder
Records
1
-
26
| BRAF more frequently co-occurs with IDH1/2 mutations in adult patients with gliomas than in patients harboring BRAF but without a survival advantage. BMC neurology 2021 May 21 (1): 195. Wang Wei, Wang Maode, Jiang Haitao, Wang Tuo, Da Ro |
| The prognostic significance of p16 expression pattern in diffuse gliomas. Journal of pathology and translational medicine 2020 Dec . Park Jin Woo, Kang Jeongwan, Lim Ka Young, Kim Hyunhee, Kim Seong-Ik, Won Jae Kyung, Park Chul-Kee, Park Sung-H |
| Variable expression of CXCR4 in molecular subtypes of infiltrating gliomas. Clinical neuropathology 2020 Dec . Dono Antonio, Zhu Ping, Zorofchian Soheil, Takayasu Takeshi, Quezado Martha M, Rios Adan, Powers Astin, Esquenazi Yoshua, Ballester Leomar |
| A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas. Cancer science 2020 Aug . Higa Nayuta, Akahane Toshiaki, Yokoyama Seiya, Yonezawa Hajime, Uchida Hiroyuki, Takajo Tomoko, Kirishima Mari, Hamada Taiji, Matsuo Kei, Fujio Shingo, Hanada Tomoko, Hosoyama Hiroshi, Yonenaga Masanori, Sakamoto Akihisa, Hiraki Tsubasa, Tanimoto Akihide, Yoshimoto Ko |
| Evaluation of the target genes of arsenic trioxide in pancreatic cancer by bioinformatics analysis. Oncology letters 2019 Nov 18 (5): 5163-5172. Zhou Cong-Ya, Gong Liu-Yun, Liao Rong, Weng Ning-Na, Feng Yao-Yue, Dong Yi-Ping, Zhu Hong, Zhao Ya-Qin, Zhang Yuan-Yuan, Zhu Qing, Han Su-X |
| Genomic analysis of primary and recurrent gliomas reveals clinical outcome related molecular features. Scientific reports 2019 Nov 9 (1): 16058. Zhang Longbo, Liu Zhiqiang, Li Jin, Huang Tianxiang, Wang Ying, Chang Lianpeng, Zheng Wenjie, Ma Yujie, Chen Fenghua, Gong Xuan, Yuan Qianying, Teaw Shannon, Fang Xinqi, Song Tao, Huo Lei, Li Xi, Xia Xuefeng, Liu Zhixiong, Wu J |
| Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma. Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto |
| Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing. Neoplasia (New York, N.Y.) 2018 Feb 20 (3): 256-262. Shajani-Yi Zahra, de Abreu Francine B, Peterson Jason D, Tsongalis Gregory |
| Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2017 30 (5): 361-371. Houdova Megova M, Drábek J, Dwight Z, Trojanec R, Koudeláková V, Vrbková J, Kalita O, Mlcochova S, Rabcanova M, Hajdúch |
| DNA methylation and leukemia susceptibility in China: Evidence from an updated meta-analysis. Molecular and clinical oncology 2016 Sep 5 (3): 193-207. Jiang Danjie, Li Yirun, Hong Qingxiao, Shen Yusheng, Xu Chunjing, Xu Yan, Zhu Huangkai, Dai Dongjun, Ouyang Guifang, Duan Shiw |
| Two gene polymorphisms (rs4977756 and rs11515) in CDKN2A/B and glioma risk in South Indian population. Meta gene 2016 Sep 9 215-8. Sibin M K, Dhananjaya I Bhat, Narasingarao K V L, Harshitha S M, Jeru-Manoj M, Chetan G |
| Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma. Journal of neuro-oncology 2016 May 127 (3): 483-92. Ghasimi Soma, Wibom Carl, Dahlin Anna M, Brännström Thomas, Golovleva Irina, Andersson Ulrika, Melin Beatri |
| BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Mar 33 (9): 1015-22. Mistry Matthew, Zhukova Nataliya, Merico Daniele, Rakopoulos Patricia, Krishnatry Rahul, Shago Mary, Stavropoulos James, Alon Noa, Pole Jason D, Ray Peter N, Navickiene Vilma, Mangerel Joshua, Remke Marc, Buczkowicz Pawel, Ramaswamy Vijay, Guerreiro Stucklin Ana, Li Martin, Young Edwin J, Zhang Cindy, Castelo-Branco Pedro, Bakry Doua, Laughlin Suzanne, Shlien Adam, Chan Jennifer, Ligon Keith L, Rutka James T, Dirks Peter B, Taylor Michael D, Greenberg Mark, Malkin David, Huang Annie, Bouffet Eric, Hawkins Cynthia E, Tabori U |
| The CDKN2A-CDKN2B rs4977756 polymorphism and glioma risk: a meta-analysis. International journal of clinical and experimental medicine 2015 8 (10): 17480-8. Lu Hongwei, Yang Yuantao, Wang Jihui, Liu Yang, Huang Ming, Sun Xinlin, Ke Yiqu |
| Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study. International journal of cancer. Journal international du cancer 2013 May 132 (10): 2464-8. Melin Beatrice, Dahlin Anna M, Andersson Ulrika, Wang Zhaoming, Henriksson Roger, Hallmans Göran, Bondy Melissa L, Johansen Christoffer, Feychting Maria, Ahlbom Anders, Kitahara Cari M, Wang Sophia S, Ruder Avima M, Carreón Tania, Butler Mary Ann, Inskip Peter D, Purdue Mark, Hsing Ann W, Mechanic Leah, Gillanders Elizabeth, Yeager Meredith, Linet Martha, Chanock Stephen J, Hartge Patricia, Rajaraman Preet |
| Analysis of 60 reported glioma risk SNPs replicates published GWAS findings but fails to replicate associations from published candidate-gene studies. Genetic epidemiology 2013 Feb 37 (2): 2. Walsh KM, Anderson E, Hansen HM, Decker PA, Kosel ML, Kollmeyer T, Rice T, Zheng S, Xiao Y, Chang JS, McCoy LS, Bracci PM, Wiemels JL, Pico AR, Smirnov I, Lachance DH, Sicotte H, Eckel-Passow JE, Wiencke JK, Jenkins RB, Wrensch MR |
| EGFR gene variants are associated with specific somatic aberrations in glioma. PloS one 2012 7 (12): 12. Wibom C, Ghasimi S, Van Loo P, Brännström T, Trygg J, Lau C, Henriksson R, Bergenheim T, Andersson U, Rydén P, Melin B |
| IDH1/2 gene status defines the prognosis and molecular profiles in patients with grade III gliomas. International journal of clinical oncology 2012 Dec 17 (6): 551-61. Shibahara Ichiyo, Sonoda Yukihiko, Kanamori Masayuki, Saito Ryuta, Yamashita Yoji, Kumabe Toshihiro, Watanabe Mika, Suzuki Hiroyoshi, Kato Shunsuke, Ishioka Chikashi, Tominaga Tei |
| Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies. Neuro-oncology 2012 Nov . Di Stefano AL, Enciso-Mora V, Marie Y, Desestret V, Labussière M, Boisselier B, Mokhtari K, Idbaih A, Hoang-Xuan K, Delattre JY, Houlston RS, Sanson M |
| Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer genetics 2011 Jan 204 (1): 13-8. Jenkins Robert B, Wrensch Margaret R, Johnson Derek, Fridley Brooke L, Decker Paul A, Xiao Yuanyuan, Kollmeyer Thomas M, Rynearson Amanda L, Fink Stephanie, Rice Terri, McCoy Lucie S, Halder Chandralekha, Kosel Matthew L, Giannini Caterina, Tihan Tarik, O'Neill Brian P, Lachance Daniel H, Yang Ping, Wiemels Joseph, Wiencke John |
| Genetic risk profiles identify different molecular etiologies for glioma. Clinical cancer research : an official journal of the American Association for Cancer Research 2010 Nov 16 (21): 5252-9. Simon Matthias, Hosking Fay J, Marie Yannick, Gousias Konstantinos, Boisselier Blandine, Carpentier Catherine, Schramm Johannes, Mokhtari Karima, Hoang-Xuan Khe, Idbaih Ahmed, Delattre Jean-Yves, Lathrop Mark, Robertson Lindsay B, Houlston Richard S, Sanson Ma |
| Interaction between 5 genetic variants and allergy in glioma risk. American journal of epidemiology 2010 Jun 171 (11): 1165-73. Schoemaker Minouk J, Robertson Lindsay, Wigertz Annette, Jones Michael E, Hosking Fay J, Feychting Maria, Lönn Stefan, McKinney Patricia A, Hepworth Sarah J, Muir Kenneth R, Auvinen Anssi, Salminen Tiina, Kiuru Anne, Johansen Christoffer, Houlston Richard S, Swerdlow Anthony |
| Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. PLoS genetics 2010 Apr 6 (4): e1000899. Cunnington Michael S, Santibanez Koref Mauro, Mayosi Bongani M, Burn John, Keavney Berna |
| Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Dec 27 (34): 5743-50. Weller Michael, Felsberg Jörg, Hartmann Christian, Berger Hilmar, Steinbach Joachim P, Schramm Johannes, Westphal Manfred, Schackert Gabriele, Simon Matthias, Tonn Jörg C, Heese Oliver, Krex Dietmar, Nikkhah Guido, Pietsch Torsten, Wiestler Otmar, Reifenberger Guido, von Deimling Andreas, Loeffler Mark |
Genome-wide association study identifies five susceptibility loci for glioma.
Nature genetics 2009 Aug 41 (8): 899-904. Shete Sanjay, Hosking Fay J, Robertson Lindsay B, Dobbins Sara E, Sanson Marc, Malmer Beatrice, Simon Matthias, Marie Yannick, Boisselier Blandine, Delattre Jean-Yves, Hoang-Xuan Khe, El Hallani Soufiane, Idbaih Ahmed, Zelenika Diana, Andersson Ulrika, Henriksson Roger, Bergenheim A Tommy, Feychting Maria, Lönn Stefan, Ahlbom Anders, Schramm Johannes, Linnebank Michael, Hemminki Kari, Kumar Rajiv, Hepworth Sarah J, Price Amy, Armstrong Georgina, Liu Yanhong, Gu Xiangjun, Yu Robert, Lau Ching, Schoemaker Minouk, Muir Kenneth, Swerdlow Anthony, Lathrop Mark, Bondy Melissa, Houlston Richard |
| Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 Aug 16 (8): 1655-61. Rajaraman Preetha, Wang Sophia S, Rothman Nathaniel, Brown Merideth M, Black Peter M, Fine Howard A, Loeffler Jay S, Selker Robert G, Shapiro William R, Chanock Stephen J, Inskip Peter |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: